Join Our Community:
Volume 02 Issue 23
June 25, 2021
Because life depends on us™
BSMA Clearing House
for latest news and information
...at a glance
ORGANIZATION NEWS!




















EXECUTIVE NEWS!
The Editorial
Pharmaceuticals and Active Pharmaceutical Ingredients - Biden Administration Issues 100-Day Supply Chain Review Report
June 24, 2021

On June 8, 2021, four Executive Branch Departments issued reports mandated by President Biden’s February 24, 2021 Executive Order on America’s Supply Chains (the “America’s Supply Chains E.O.” or the “E.O.”). The E.O. directed the federal government to assess the supply chains of four critical products: (1) semiconductor manufacturing and advanced packaging; (2) large capacity batteries; (3) critical minerals and materials; and (4) pharmaceuticals and active pharmaceutical ingredients (“APIs”). The four reports have been consolidated into a report to the President (the “100-Day Report”), and on June 8, the Biden Administration issued a Fact Sheet and held a press briefing about the reports. As we wrote in February, the 100-Day Report will be followed by six additional sector-specific supply chain assessments that are due by February 24, 2022.
  • This Industry-Specific Primer focuses on the “Review of Pharmaceuticals and Active Pharmaceutical Ingredients” section of the 100-Day Report that was coordinated by the U.S. Department of Health and Human Services (“HHS”) (the “Pharmaceuticals and API Report”). The Pharmaceuticals and API Report identifies both immediate and long-term actions needed to strengthen the domestic manufacture of critical drug products and APIs, reduce dependence on foreign nations for supply chain

INNOVATIONS!
INFRASTRACTURE
CHALLENGES & SOLUTIONS!

















UPCOMING EVENTS:

~~~~~~~
University Industry Initiative Webinar
Collaborations between companies and academic institutions can yield great benefits – translation of research into products, discovery of new approaches and techniques, talent development, and more. Rich in potential benefits, such collaborations are not necessarily easy to launch. Whether you’re on the university or industry side, you want to understand best practices in these arrangements. That’s what this interactive webinar will provide: the who, what, when, where, why, and how of successful university-industry collaborations. Our panel of experts will share their experiences and tips – plus identify pitfalls to avoid.
For Details, Click Here

~~~~~~~

“Commercialization Of Cell & Gene Therapy: ADVANCING TECHNOLOGY AND INNOVATION”    

The innovative therapy of Cell and Gene Therapy has imposed Draconian demands on the supply chain in terms of production batch of one, sixteen-day vein to vein lead time, cryogenic preservation and cold-chain logistics, chain of custody, real-time patient care, and prohibitive cost of treatment. Executives of CGT companies and service providers will address the “Issues and Answers” of raw material supply, supplier QA, apheresis, scale out of clinical and manufacturing operations, distribution and logistics, information systems, governmental compliance and efficacy of treatment.
For Details, Click Here

~~~~~~~
Visit our online Calendar for other events
~~~~~~~
BSMA USA Conference, Oct. 20
Details In Progress
Message from the BSMA Team: Please stay safe...wash your hands, don't touch any part of your face after being out and about, wear a mask to avoid touching your face or if you are coughing, keep the social distancing rule, and most of all be patient, positive, and proactive ... and we need to be kind to each other. Thank you.
Editor:
Devendra Mishra
Executive Director & Co-Founder
BSMA
+1-818-224-1552
Editor:
Dotti Yells
VP, Marketing Technology
BSMA